FDA's MAPP on Complex Product Classification for Generic Development
HPRA Guide to Parallel Imports of Human Medicines - Ireland
FDA Guidance:Providing Submissions in Electronic & Non-Elec Format—Promotional Labeling &Advertising
EMA Draft Guidance- How To Approach the Protection Clinical Trial Information System (CTIS)
ICH-Draft Guideline on Pediatric Extrapolation & FInal Guidance on Considerations for Clinical Study
Voluntary GVP Inspection on Pharma Product Registration Holders- Malaysia’s NPRA
ICH's updated Draft Guidelines on Analytical Method Development
Guide on Microplastic Usage - IPEC Europe and IPEC-Americas "How to Document"
EMA Guidance on Post-Authorisation Procedural Advice for CAP users & EudraVigilance Reg. Manual
EMA Guidance on GVP for PPP & Parallel EMA/EUnetHTA 21 Consultation
Guidance on Renewal & Discontinuation of Authorisation on change of Status -Swiss Medic
UK MHRA: Guidance on "Advertise your Medicines"
FDA's: OTC Monograph Drug User Fees for Fiscal Year 2022
SwissMedic Guidance on Packaging for Human Medicinal Products
UK (MHRA) Project Orbis Guidance Update & New Guidance on Dialysis
USFDA: 3 updated Guidance on PLAIR, VQIP & Recalls
South Africa (SAHPRA) Guidance on How to Submit Variation Applications
MHRA adds Health Technology Assessments (HTA) Tool Details to ILAP Guide
USFDA Guidance: Methods to Identify What Is Important to Patients
EU Guidelines for Good Manufacturing Practice for Medicinal Products